Biopharmaceutical and
Medical Device Companies

Lower Development Costs with Clinipace's TEMPO

In addition to recent drug safety concerns, pharmaceutical companies are focusing new drug discoveries on smaller, targeted populations. Combined with market dynamics limiting the revenue potential of other drugs, life science companies are being forced to lower development costs and bring more drugs to market. Since clinical trials account for the bulk of the costs associated with taking a new drug to market, finding cost-lowering efficiencies is growing increasingly important.

Pharmaceutical companies seeking to migrate to an integrated clinical data capture and study management platform have found the right partner in Clinipace. Our TEMPO platform can help your company realize significant cost savings, as well as time, efficiency, and quality gains over traditional paper-based methodologies and costly clinical software packages that require complex installation and integration practices.